Phase 1 SPECT Clinical Trials
18 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–18 of 18 trials
Recruiting
Phase 1
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Neuromyelitis Optica Spectrum Disorder (NMOSD)Multiple Sclerosis (MS)Myasthenia Gravis (MG)+3 more
Tongji Hospital6 enrolled1 locationNCT07526493
Recruiting
Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine35 enrolled1 locationNCT02637934
Recruiting
Phase 1
Psilocybin for Treatment-Resistant Depression in Autism
Autism Spectrum DisorderTreatment Resistant Depression
Centre for Addiction and Mental Health20 enrolled1 locationNCT06731621
Recruiting
Phase 1Phase 2
Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.
HealthyGastrointestinal DiseasesAutism Spectrum Disorder
Chang Gung Memorial Hospital60 enrolled1 locationNCT06290258
Recruiting
Phase 1Phase 2
Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study
AutismAutism Spectrum DisorderAutism Spectrum Disorder (ASD)+1 more
Adia Med of Winter Park LLC100 enrolled1 locationNCT07304440
Recruiting
Phase 1Phase 2
Ofatumumab in AQP4-IgG Seropositive NMOSD
Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital5 enrolled1 locationNCT05504694
Recruiting
Phase 1
The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders
Neuromyelitis Optica Spectrum Disorders
Tongji Hospital69 enrolled1 locationNCT06620809
Recruiting
Phase 1
Cannabidiol (CBD) in Adults With ASD
Autism Spectrum Disorder
Johns Hopkins University40 enrolled1 locationNCT05015439
Recruiting
Phase 1Phase 2
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM)
PIK3CA-Related Overgrowth Spectrum (PROS)PIK3CA-related Vascular Malformations (PRVM)
Haihe Biopharma Co., Ltd.141 enrolled4 locationsNCT06975618
Recruiting
Phase 1
WMT for Autism Spectrum Disorder (ASD)
Autism Spectrum Disorder
The Second Hospital of Nanjing Medical University80 enrolled2 locationsNCT06030752
Recruiting
Phase 1
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
Myasthenia GravisSystemic Lupus Erythematosus (SLE)Multiple Sclerosis (MS)+3 more
RenJi Hospital30 enrolled1 locationNCT06249438
Recruiting
Phase 1Phase 2
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Myasthenia GravisNMO Spectrum DisorderChronic Inflammatory Demyelinating Polyradiculoneuropathy+1 more
Tianjin Medical University General Hospital27 enrolled1 locationNCT07022197
Recruiting
Phase 1
A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases
Myasthenia GravisMultiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disease (NMOSD)+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology37 enrolled3 locationsNCT06869278
Recruiting
Phase 1Phase 2
Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders
NMO Spectrum Disorder
Tianjin Medical University General Hospital12 enrolled1 locationNCT05792462
Recruiting
Phase 1
Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder
Autism Spectrum Disorder
Intra-Cellular Therapies, Inc.26 enrolled8 locationsNCT06557902
Recruiting
Phase 1
APP-based Emotion Recognition Training Improve ASD Social Function
Autism Spectrum Disorder High-Functioning
University of Electronic Science and Technology of China50 enrolled1 locationNCT06421272
Recruiting
Phase 1Phase 2
Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder
Autism Spectrum DisorderGastrointestinal Symptoms
The University of Texas Health Science Center, Houston70 enrolled1 locationNCT03514784
Completed
Phase 1
A prospective, open label study to evaluate the safety and pharmacokinetics of ML-004-ER under fed and fasted conditions in healthy adult volunteers
Management of patients with autism spectrum disorder
MapLight Therapeutics Inc12 enrolled1 locationACTRN12621000461897